Internal Medicine, Gastroenterology · Baltimore, MD
NPI
1700847860
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
301 Saint Paul St Ste 718
Baltimore, MD, 21202
Phone (410) 332-9356
Groups this clinician bills Medicare through
Medicare paid, 2024
$189K
2,150 services
Medicare patients, 2024
914
Average age 70
Drug cost, 2024
$2.0M
2,423 prescriptions
Company payments, 2025
$203K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anurag Maheshwari was code 99214 (office e&m - established), 502 times for 374 patients. In total Anurag Maheshwari billed 2,150 services in 35 codes, and Medicare paid $189K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 502 | 374 | $92.32 | $46K |
| 99214 Office E&M - Established | Facility | 319 | 238 | $71.54 | $23K |
| 99204 Office E&M - New | Office | 187 | 187 | $122.54 | $23K |
| 99232 Hospital E&M - Subsequent | Facility | 133 | 46 | $63.75 | $8,479 |
| 99204 Office E&M - New | Facility | 109 | 109 | $98.92 | $11K |
| 90739 Vaccine Product | Office | 108 | 67 | $161.80 | $17K |
| 91200 Standard X-ray | Facility | 108 | 105 | $7.73 | $835 |
| 43239 Upper GI Endoscopy | Facility | 85 | 79 | $74.82 | $6,360 |
| G0010 Administration of hepatitis b vaccine | Office | 83 | 56 | $32.88 | $2,729 |
| 90472 Vaccine Administration | Office | 67 | 49 | $11.72 | $785 |
| 45385 Colonoscopy - Lesion Removal | Facility | 66 | 62 | $215.72 | $14K |
| 45380 Lower GI Endoscopy - Other | Facility | 51 | 50 | $86.19 | $4,396 |
| 99222 Hospital E&M - Initial | Facility | 42 | 39 | $105.88 | $4,447 |
| 90471 Vaccine Administration | Office | 35 | 30 | $16.24 | $568 |
| 43235 Upper GI Endoscopy | Facility | 34 | 34 | $81.63 | $2,775 |
By year: 2022 $201K for 2,220 services; 2023 $176K for 1,922 services; 2024 $189K for 2,150 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anurag Maheshwari prescribed most often to Medicare patients was Ursodiol, with 239 prescriptions and refills. In total Anurag Maheshwari wrote 2,423 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ursodiol Generic | 239 | 534 | 58 | $52K |
| Pantoprazole Sodium Generic | 225 | 615 | 87 | $4,598 |
| Spironolactone Generic | 121 | 307 | 45 | $2,353 |
| Tacrolimus Generic | 115 | 281 | 26 | $24K |
| Carvedilol Generic | 107 | 300 | 36 | $1,287 |
| Xifaxan Rifaximin | 102 | 108 | 20 | $334K |
| Furosemide Generic | 86 | 206 | 28 | $477 |
| Omeprazole Generic | 84 | 232 | 33 | $1,338 |
| Entecavir Generic | 83 | 179 | 16 | $43K |
| Lactulose Generic | 66 | 108 | 30 | $4,986 |
| Ciprofloxacin Hcl Generic | 61 | 79 | 27 | $792 |
| Sucralfate Generic | 60 | 134 | 22 | $2,799 |
| Prednisone Generic | 55 | 151 | 23 | $513 |
| Famotidine Generic | 54 | 135 | 16 | $829 |
| Azathioprine Generic | 53 | 151 | 18 | $2,435 |
Brand drugs: - claims; generic drugs: 2,036 claims; opioid claims: 30.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anurag Maheshwari $203K ($203K in general payments such as food, travel and fees) from 17 companies. The largest payer was Madrigal Pharmaceuticals with $65K.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 59 | $65K |
| Novo Nordisk Inc NVO | 23 | $41K |
| Gilead Sciences, Inc. GILD | 39 | $30K |
| Ferring Pharmaceuticals Inc. | 26 | $23K |
| Intercept Pharmaceuticals, Inc. | 23 | $19K |
| Abbvie Inc. ABBV | 31 | $12K |
| Eisai Inc. 4523.T | 10 | $9,622 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 11 | $2,544 |
| Janssen Biotech, Inc. JNJ | 1 | $67.45 |
| Boston Scientific Corporation BSX | 1 | $36.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.